Clinical Trials Browser

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Mastocytosis, Myositis, Sjogren's Syndrome, Vasculitis, Arthritis, Psoriatic, Antiphospholipid Syndrome, Spondylarthritis, Rare Diseases, Scleroderma, Diffuse

NCT03713736 2021-07-27

PAPLOR

Phase NA Unknown

385 enrolled

Spondylarthritis, Papillomavirus Infections

NCT04953871 2021-07-08

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

Phase 4 Completed

31 enrolled

Spondylarthritis

NCT02492217 2020-11-03

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Phase 4 Completed

69 enrolled

Spondylitis, Ankylosing, Spondylarthritis

NCT02364479 2019-12-19

Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein

Phase 4 Completed

150 enrolled

Recurrence, Spondylarthritis

NCT01590966 2019-08-26

SCINTRA

Phase 3 Completed

41 enrolled

Arthritis, Rheumatoid, Spondylarthritis

Clinical Trials

EGR2

PAPLOR

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein

SCINTRA